Achilles Therapeutics plc
NASDAQ:ACHL
1.045 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 131.539 | 173.338 | 266.319 | 177.849 | 97.594 | 10.683 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 131.539 | 173.338 | 266.319 | 177.849 | 97.594 | 10.683 |
| Net Receivables
| 10.351 | 16.003 | 11.173 | 7.339 | 4.486 | 0 |
| Inventory
| 0 | 4.624 | 5.133 | 1.758 | 0.504 | 0 |
| Other Current Assets
| 3.743 | 2.615 | 2.124 | 0.851 | 0.477 | 2.693 |
| Total Current Assets
| 145.633 | 196.58 | 284.749 | 187.797 | 103.061 | 13.376 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 13.543 | 20.48 | 28.791 | 28.109 | 2.11 | 0.583 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| -0 | -0.033 | -0.033 | 0 | 0 | 0 |
| Long Term Investments
| 0.033 | 0.033 | 0.033 | 0 | 0 | 0 |
| Tax Assets
| 0.041 | 0.251 | 0.026 | 0.004 | 0 | 0 |
| Other Non-Current Assets
| 2.206 | 3.047 | 3.54 | 3.008 | 0.034 | 0 |
| Total Non-Current Assets
| 15.823 | 23.778 | 32.357 | 31.121 | 2.144 | 0.583 |
| Total Assets
| 161.456 | 220.358 | 317.106 | 218.918 | 105.205 | 13.959 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 5.629 | 5.187 | 3.722 | 6.314 | 0.902 | 0.129 |
| Short Term Debt
| 3.539 | 4.188 | 4.482 | 3.712 | 0.487 | 0 |
| Tax Payables
| 0 | 0.326 | 0 | 0.007 | 0 | 0 |
| Deferred Revenue
| -5.629 | 0 | 9.638 | 5.227 | 1.787 | 0 |
| Other Current Liabilities
| 13.457 | 8.618 | 1.268 | 1.37 | 0.681 | 1.157 |
| Total Current Liabilities
| 16.996 | 17.993 | 19.11 | 16.623 | 3.857 | 1.286 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 1.076 | 4.388 | 7.777 | 12.271 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.015 | 0.933 | 0.691 | 0.652 | 0 | 0 |
| Total Non-Current Liabilities
| 2.091 | 5.321 | 8.468 | 12.923 | 0 | 0 |
| Total Liabilities
| 19.087 | 23.314 | 27.578 | 29.546 | 3.857 | 1.286 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0.134 | 0.079 | 0 |
| Common Stock
| 0.182 | 0.054 | 0.054 | 0.025 | 0.014 | 0 |
| Retained Earnings
| -259.952 | -190.287 | -119.111 | -58.012 | -24.813 | -10.823 |
| Accumulated Other Comprehensive Income/Loss
| -13.071 | -21.695 | 6.636 | 12.322 | 8.109 | -0.395 |
| Other Total Stockholders Equity
| 415.21 | 408.972 | 401.949 | 234.903 | 117.959 | 23.891 |
| Total Shareholders Equity
| 142.369 | 197.044 | 289.528 | 189.372 | 101.348 | 12.673 |
| Total Equity
| 142.369 | 197.044 | 289.528 | 189.372 | 101.348 | 12.673 |
| Total Liabilities & Shareholders Equity
| 161.456 | 220.358 | 317.106 | 218.918 | 105.205 | 13.959 |